pharma-company /Medicinal products /Active ingredients

Rx · PZN 20319525

OJEMDA 25 mg/ml powder for preparation of a suspension for oral use 300mg

German trade nameOJEMDA 25 mg-ml Pulver zur Herstellung einer Suspension zur Einnehmen 300mg

Active ingredientTovorafenib

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Ambient 15–25 °C

Highest known
purchase price (B2B)

~ €3,930

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for OJEMDA 25 mg/ml powder for preparation of a suspension for oral use 300mg.

Review purchasing terms

OJEMDA 25 mg/ml powder for preparation of a suspension for oral use 300mg contains the active ingredient Tovorafenib. One pack size is recorded (PZN 20319525). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


OJEMDA 25 mg/ml powder for preparation of a suspension for oral use 300mg was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.